New prospects for the treatment of germ-cell tumours

Expert Opinion on Investigational Drugs

Volumn 7, Issue 7, 1998, Pages 1139-1157

  Droz, J P ^a   Culine, S ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Anticancer drugs; Experimental chemotherapy; Germ cell lines; Germ cell tumours; Phase II trials; Phase III trials; Treatment strategy

Indexed keywords

AMSACRINE; ANTHRACYCLINE ANTIBIOTIC AGENT; BLEOMYCIN; CARBOPLATIN; CHLORMETHINE; CISPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; LOBAPLATIN; METHOTREXATE; MITHRAMYCIN; MITOGUAZONE; MITOMYCIN; MITOXANTRONE; NAVELBINE; OXALIPLATIN; PACLITAXEL; TOPOTECAN; VINBLASTINE; VINDESINE;

DOSE RESPONSE; DRUG EFFICACY; GERM CELL TUMOR; HUMAN; METASTASIS; OVARY CANCER; RECURRENT DISEASE; REVIEW; RISK FACTOR; TESTIS CANCER; TREATMENT FAILURE;

EID: 0031926303     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.7.1139     Document Type: Review

References (115)